8307 — Medicskin Holdings Income Statement
0.000.00%
Last trade - 00:00- HK$55.15m
- HK$60.60m
- HK$45.11m
Annual income statement for Medicskin Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 41.7 | 49.1 | 45.5 | 49.1 | 45.1 |
| Cost of Revenue | |||||
| Gross Profit | 34.4 | 42.1 | 36.7 | 39.4 | 36.6 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 39.9 | 44.3 | 48.5 | 51.8 | 47.9 |
| Operating Profit | 1.8 | 4.82 | -2.92 | -2.62 | -2.77 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 1.31 | 4.42 | -3.7 | -3.12 | -3.46 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.36 | 4.14 | -3.59 | -3.1 | -3.38 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.953 | 3.92 | -3.54 | -3.05 | -3.38 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.953 | 3.92 | -3.54 | -3.05 | -3.38 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0 | 0.01 | -0.01 | -0.008 | -0.008 |
| Dividends per Share |